BioAsia 2012 from February 09; GVK Biosciences is Co-Industry Host
February 07, 2012
Hyderabad — February 07, 2012 — The ninth edition of BioAsia, the annual global bio business forum, is slated to get underway from February 09, 2012 at HICC here.
For this edition, BioAsia 2012, over 250 companies have confirmed their participation according to the organizers, Federation of Asian Biotech Associations (FABA). This year the country partners include Sri Lanka, Belgium, Germany and Korea. In all 35 countries have confirmed their participation with major delegations coming from Sri Lanka, Korea, Iran, Germany, Belgium, Pennsylvania, Singapore, Egypt, Africa, Thailand, Nepal among others. Further, regulators from 10 countries will be participating in this event. The organizers also informed that the Governments of Karnataka, Gujarat and Tamil Nadu had already confirmed participation. GVK Biosciences will be the co-host for the event.
Talking about their association with BioAsia, Mr. Manni Kantipudi, CEO, GVK BIO said, “BioAsia provides a platform for companies to exhibit, launch and showcase their products and services. GVK Biosciences has been associated with BioAsia for the past several years as BioAsia provides an opportunity to network and forge new business relationships. I expect BioAsia to be well attended this year due to greater industry participation (domestic and international) and better marketing by the organizers.”
The Andhra Pradesh Chief Minister, N Kiran Kumar Reddy, will be the chief guest for the occasion. The guests of honor, Dr. (Smt) J Geeta Reddy, Minister for major industries, commerce and export promotion and Prof. Tissa Vitarana, Senior Minister for Scientific Affairs, Government of Sri Lanka will also be attending together with the Genome Valley Excellence awardees Dr. Seth Berkley, CEO, GAVI Alliance and Dr. Kevin Ali, President, Emerging Markets, Merck & Co.
The partners for BioAsia 2012 include Frost & Sullivan, Confederation of Indian Industries, Alexandria India, Lonza India, Hyde Engineering & Consulting and Yes Bank. Further, the organizers announced the support from various parts of the globe through regional industry associations like SwedenBIO, Swiss Biotech, AusBiotech, Biocat (Spain), etc.
BioAsia 2012 has already attracted high profile speakers and global thought leaders like Dr. Richard Connell, Vice President and Head of R & D, Pfizer, Shanghai; Dr. Ajit Shetty, President, Johnson & Johnson, Dr. Hasit Joshipura, VP and MD, GSK, Mr. Pankaj Patel, Chairman, Zydus Cadila, Dr. N K Ganguly, Chairman, Immunology Foundation & Former Director General, Indian Council for Medical Research, Dr. Suresh Jadhav of Serum Institute of India, Dr. Darren JI, Chief Executive Officer, PharmaLegacy Labs, China; Dr. Cyrus Karkaria, President Biotech, Lupin (India), among others. The CEO Conclave at BioAsia 2012 has already attracted 30 industry captains which include GSK, Natco Pharma, Bharat Biotech, Shantha Biotech, Pfizer, Abbott, Ranbaxy, Lupin, etc.
BioAsia is the forum for biotechnology business community across the globe. The forum has been active since 2004 assisting biotech and pharmaceutical companies around the world to create new business partnerships, academic and industrial collaboration and for exploring and sharing the resources. The Government of Andhra Pradesh has taken the lead to organize BioAsia every year in association with Federation of Asian Biotech Associations (FABA), All India Biotech Association and University of Hyderabad.
About GVK Biosciences
GVK Biosciences (GVK BIO) is Asia’s leading contract research organization. GVK BIO provides a broad spectrum of services, stand-alone and integrated, across the R&D value chain. Our discovery services consist of Chemistry, Biology and Informatics; the development services include Clinical Research, Clinical Pharmacology and Process R&D. GVK BIO’s diverse portfolio of more than 150 customers includes some of the world’s largest pharmaceutical, biotechnology, agro, life-sciences companies and leading academic institutions.